|
|
.
NPI Detail
NPI: 1528042884
Type: Organization
Taxonomy Code: 273Y00000X
Hospital-Rehabilitation Unit
Hospital Units/Rehabilitation Unit
8900 X XXXXXXX XX
MIAMI, FL 331762118
Business phone: (XXX) XXX-XXXX
Mailing address phone: (XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1528042884*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXX.XX
|
| 88185
|
FLOWCYTOMETRY/TC ADD-ON
|
XXXXX
|
-
|
| 97110
|
THERAPEUTIC EXERCISES
|
XXXXX
|
$XXXXXX.XX
|
| 80053
|
COMPREHEN METABOLIC PANEL
|
XXXXX
|
$XXXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J1642
|
Inj heparin sodium per 10 u
|
XXXXXX
|
-
|
| J1439
|
Inj ferric carboxymaltos 1mg
|
XXXXXX
|
$XXXXX.XX
|
| J9267
|
Paclitaxel injection
|
XXXXX
|
-
|
| J9271
|
Inj pembrolizumab
|
XXXXX
|
$XXXXXXX.XX
|
| J0185
|
Inj., aprepitant, 1 mg
|
XXXXX
|
$XXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXXX
|
-
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXXX
|
$XXXXXX.XX
|
| J9306
|
Injection, pertuzumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J9299
|
Injection, nivolumab
|
XXXXX
|
$XXXXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXXX
|
$XXXXXX.XX
|
| J2704
|
Inj, propofol, 10 mg
|
XXXXX
|
-
|
| J1442
|
Inj filgrastim excl biosimil
|
XXXXX
|
$XXXXX.XX
|
| J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J9025
|
Azacitidine injection
|
XXXXX
|
$XXXXX.XX
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXX
|
$XXXXXXX.XX
|
| J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
| J0131
|
Inj, acetaminophen (nos)
|
XXXXX
|
-
|
| J1756
|
Iron sucrose injection
|
XXXXX
|
-
|
| J9171
|
Docetaxel injection
|
XXXXX
|
-
|
| J9035
|
Bevacizumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J9355
|
Inj trastuzumab excl biosimi
|
XXXXX
|
$XXXXXX.XX
|
| J9349
|
Inj., tafasitamab-cxix
|
XXXXX
|
$XXXXXX.XX
|
| J2405
|
Ondansetron hcl injection
|
XXXXX
|
-
|
| J1453
|
Fosaprepitant injection
|
XXXXX
|
$XXXX.XX
|
| J0461
|
Atropine sulfate injection
|
XXXXX
|
-
|
| J9030
|
Bcg live intravesical 1mg
|
XXXXX
|
-
|
| J9176
|
Injection, elotuzumab, 1mg
|
XXXXX
|
$XXXXX.XX
|
| J9305
|
Inj. pemetrexed nos 10mg
|
XXXXX
|
$XXXXXX.XX
|
| J9354
|
Inj, ado-trastuzumab emt 1mg
|
XXXXX
|
$XXXXXX.XX
|
| J9041
|
Injection, bortezomib, 0.1mg
|
XXXXX
|
$XXXXXX.XX
|
| J9119
|
Inj., cemiplimab-rwlc, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0378
|
Hospital observation per hr
|
XXXXX
|
-
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
